Clinical and Immunological Features of COVID-19 Neuroimmune Complications in China
Author Information
Author(s): Gong Siyin, Deng Bo, Yu Hai, Zhang Xiang, Yang Wenbo, Chen Xiangjun
Primary Institution: Huashan Hospital, Fudan University
Hypothesis
This study aimed to present clinical and immunological features in patients with neuroimmune complications of COVID-19 during the Omicron wave in China.
Conclusion
The manifestations of neuroimmune complications of COVID-19 are diverse and can manifest with severe neurological deficits early in the course of the disease.
Supporting Evidence
- Neuroimmune complications included Guillain-Barre syndrome, myelitis, and autoimmune encephalitis.
- SARS-CoV-2 was detected in the CSF of only one patient with neuroimmune complications.
- Immunotherapy improved outcomes in a significant proportion of patients.
- Baseline modified Rankin scale scores indicated severe functional impairments in most patients.
- 90-day follow-up showed significant functional recovery in many patients.
Takeaway
This study looked at how COVID-19 can cause serious brain problems in some people, especially during the Omicron wave, and found that treatments can help improve their condition.
Methodology
Patients with neuroimmune complications associated with COVID-19 were retrospectively analyzed, including demographic information, symptoms, and treatment outcomes.
Potential Biases
Selection bias due to the retrospective nature of the study.
Limitations
The study has small sample sizes, selection bias, incomplete laboratory data, and short-term follow-up.
Participant Demographics
Patients ranged in age from 13 to 77 years, with a majority being male.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website